IMST for Chronic Kidney Disease and High Blood Pressure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to lower high blood pressure in individuals with chronic kidney disease using inspiratory muscle strength training (IMST). IMST involves breathing exercises to enhance muscle strength, potentially aiding in blood pressure control and improving blood vessel health. Participants will engage in either high-resistance or low-resistance breathing exercises. The trial seeks individuals over 50, post-menopausal if female, with moderate-to-severe chronic kidney disease, and difficulty maintaining low blood pressure despite medication. As an unphased trial, this study provides a unique opportunity to explore innovative treatments that could enhance health and well-being.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be on a stable blood pressure medication regimen for at least 6 weeks before joining the study.
What prior data suggests that this inspiratory muscle strength training is safe for individuals with chronic kidney disease and high blood pressure?
A previous study showed that high-resistance inspiratory muscle strength training (IMST) is a promising and safe method. Research suggests it can help lower blood pressure and improve blood vessel function. This training is quick and may be easier for people to maintain compared to other exercises. Earlier studies have reported no major safety issues. The trial remains in an early stage, so researchers continue to gather detailed safety information. However, the absence of major side effects so far suggests that IMST could be well-tolerated by participants.12345
Why are researchers excited about this trial?
Inspiratory Muscle Strength Training (IMST) is unique because it offers a non-invasive, drug-free approach to managing chronic kidney disease and high blood pressure. Unlike standard treatments that often rely on medications like ACE inhibitors or diuretics, IMST focuses on strengthening respiratory muscles through high-resistance breathing exercises. Researchers are excited about this technique because it could improve cardiovascular health and kidney function by enhancing respiratory efficiency, potentially leading to better patient outcomes without the side effects associated with long-term medication use.
What evidence suggests that IMST is effective for chronic kidney disease and high blood pressure?
Research has shown that a breathing exercise called high-resistance inspiratory muscle strength training (IMST), which participants in this trial may receive, can help lower blood pressure. One study found that participants' top blood pressure number dropped from 135 to 126, with this improvement mostly lasting six weeks after completing the training. This method shows particular promise for people with chronic kidney disease, who often experience high blood pressure. IMST strengthens the muscles used for breathing, which appears to improve blood flow and lower blood pressure. These findings suggest that IMST can effectively enhance heart health in individuals with kidney problems.12567
Who Is on the Research Team?
Michel B Chonchol, MD
Principal Investigator
University of Colorado, Denver
Kristen Nowak, PhD, MPH
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
Adults over 50 with moderate-to-severe chronic kidney disease and high blood pressure that's not well-controlled, despite being on stable medication for at least 6 weeks. Participants should be non-smokers, not have had recent hospitalizations or severe heart failure, and cannot be using immunosuppressants or have significant lung diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle strength training (IMST) or sham training for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- IMST
- Sham Training
IMST is already approved in United States, European Union for the following indications:
- Chronic Kidney Disease
- Hypertension
- Chronic Kidney Disease
- Respiratory Muscle Weakness
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
University of Colorado, Boulder
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator